Professor
Epidemiologist and harm reduction lead BC Centre for Disease Control
MBBS (Medicine), MHSc (Community Medicine), FRCPC (Community Medicine)
 
Rm 107, 2206 East Mall
Vancouver, BC V6T 1Z3
phone: 6048274001
fax: 6048224994
phone: 6047072573

Jane Buxton is a professor and practicum director of the Masters of Public Health program in the School of Population and Public Health.

She works half time as physician epidemiologist at BC Centre for Disease Control (BCCDC) where she leads surveillance for hepatitis and bloodbourne pathogens and is harm reduction lead.

Jane gained her medical degree in London (UK) and worked as a family physician for 7 years. She came to Canada and completed her Public Health and Preventive Medicine (formerly Community medicine) residency at UBC in 1999 and is a graduate of Health Canada federal field epidemiology program.

She is committed to undergraduate and post graduate student public health education. Over the past 10 years she has been primary supervisor for over a 100 students on placement at BCCDC (medical students, residents, MPH practicum students etc) where she shares her passion for public health and engages students in public health practice and applied public health research. She supervises MSc and PhD students in SPPH.

Her national postgraduate education roles include being on the Royal College examination board and she is Chair of the Royal College Public Health and Preventive Medicine Specialty Committee which oversees the standards of residency specialty training nationally.

Her research in illegal drug use epidemiology and harm reduction is recognized internationally and nationally. She developed the inter-sectoral Drug Overdose and Alert Partnership (DOAP) to ensure timely identification of drug related harms and dissemination to those who need to know. She is engaged in quantitative, qualitative and participatory research with marginalized populations and believes people who use drugs should be involved in developing priorities for research, policy and harm reduction program evaluation. Jane co-chairs the BC Harm Reduction Strategies and Services and in August 2012 led the introduction of the BC overdose prevention and take-home-naloxone program.

Jane is the proud recipient of the 2012 James M. Robinson Award for significant contribution to public health awarded by SPPH and the 2013 BC Provincial Health Officer’s Award for Excellence in Public Health ‘for persistent and pioneering work to bring equitable harm reduction services and supplies to all of British Columbia.’

2013 Faculty of Medicine Killam Teaching Prize
2013 BC Provincial Health Officer’s Award for Excellence in Public Health
2012 James M. Robinson Award for significant contribution to public health
2008 CJG Mackenzie Prize for Excellence in Teaching

Courses
SPPH 505 Scientific Basis for Epidemiological Thinking
SPPH 508 Master of Public Health Practicum

Regular invited guest speaker
SPPH 515 (standard and DL) Surveillance of illegal drug use
SPPH 520 (standard and DL) Bloodborne pathogens
SPPH 540 (standard and DL) Evaluation of BC harm reduction program

Graduate Student(s)
Supervisor
Alexis Crabtree, MD/PhD
Darlene Taylor, PhD
Lianping Ti, PhD
Ehsan Jozaghi, PhD

Al-Rahim Habib Msc
Jason Devlin, MSc
Stephanie Lake MSc

Committee member
Rielle Capler PhD (interdisciplinary studies)
Gareth Mercer MD/PhD

Post Graduate Students
Ehsan Jozaghi, PhD

SELECTED PUBLICATIONS
Kuo M, Shamsian A, Tzemis D, Buxton JA A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012.Harm Reduction Journal  (2014) 11:13

Coser LR, Tozer K, Van Borek N, Tzemis D, Taylor D, Saewyc E,  Buxton JA, Finding a Voice: Participatory Research with Street-Involved Youth in the Youth Injection Prevention (YIP) Project.  Health Promotion Practice (2014) Epub ahead of print PMID: 24668583

Omura J, Buxton J, Kaczorowski J, Catterson J, Li J, Badenhorst C, Derban A, Dobson S, Hasselback P, Linekin M, Machin S, McRae J, Morgana T, O’Briain B, Scheifele D, Dawar M. Immunization delivery in British Columbia: a view from the front lines. Canadian Family Physician (2014) 60(3) e187-93

Tzemis D, Campbell J, Kuo M, HRSS committee, Buxton JA. A cross-sectional study of public attitudes towards safer drug use practices in British Columbia, Canada. Substance Abuse Treatment, Prevention, and Policy  (2013) 8:40 HIGHLY ACCESSED

Filek H, Harris J, Koehn J, Oliffe J, Buxton J, Martin R. Students’ Experiences of Prison Health Education during Medical School. Medical Teacher June 2013 ID: 827330

Crabtree A, Mercer G, Horan R, Grant S, Tan T, Buxton J.  A qualitative study of the perceived effects of blue lights in washrooms on people who use injection drugs.  Harm Reduction Journal (2013) 10:22

Buxton JA, McIntyre CC, Tu AW, Eadie B, Remple VP, Halperin B, Pielak KL. Who knows more about immunization: A survey of public health nurses and physicians? Canadian Family Physician (2013) 59: e514-e52

Persaud S. Tzemis T, Kuo M, Bungay V, Buxton JA. Controlling Chaos: the perceptions of crack cocaine users in Vancouver. Journal of Addiction, 2013 Article ID 851840

Brunings P, Klar SA, Butt G, Nijkamp MD, Buxton JA. “It’s a big part of our lives.” Defining quality of hepatitis C care from patient’s perspective: A qualitative study.” Gastroenterology Nursing (2013) 36(4)249-257

Taylor D, Masse LC, Ho A, Rekart ML, Tyndall M, Henry B, Clifton J, Peters L, Ogilvie G, Buxton JA. A brief tool to assess capacity to consent for medical care among homeless individuals with problematic substance use: Study protocol. Archives of Public Health (2013) 71:11

Stockwell T, Zhao J, Martin G, Macdonald S, Vallance K, Treno A. Ponicki WR, Tu A, Buxton J. Minimum alcohol prices and outlet densities in British Columbia, Canada: Estimated impacts on alcohol attributable hospital admissions. [Epub ahead of print] Am J Public Health 2013.301289 (Co-I)

Bottorff JL, Bissell LJL, Balneaves LG, Oliffe JL, Capler R, Buxton J. Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study. Harm Reduction Journal (2013) 10 (1): 2 DOI: 10.1186/1477-7517-10-2  HIGHLY ACCESSED

Zhao J, Stockwell T, Martin G, Macdonald S, Vallance K, Treno A. Ponicki WR, Tu A, Buxton J. The relationship between changes to minimum alcohol prices, outlet density and alcohol-attributable deaths in British Columbia, 2002-2009. Addiction 108: doi: 10.1111/add.12139

Guest editor with Martin RE, Smith M, Hislop TG; BC Medical Journal 2012 54 (10) The health of incarcerated women of BC

Martin RE, Hanson D, Hemingway C, Ramsden VR, Buxton JA, Granger-Brown A, Condello LL, Macaulay AC, Janssen PA, Hislop TG: Homelessness as viewed by incarcerated women :participatory research. International Journal of Prisoner Health. (2012) 8 (3/4) 108 – 116

Ti L,Tzemis D, Buxton JA. Peer engagement in the context of policy and program development: A review of the literature Substance Abuse Treatment, Prevention, and Policy ( 2012) 7:47 (HIGHLY ACCESSED)

Funk A, Van Borek N, Taylor D, Grewal P, Tzemis D, Buxton JA. Climbing the ‘Ladder of Participation’: Engaging experiential youth in a participatory research project. CJPH (2012) 103(4) 288-92

Jafari S, Buxton JA Copes R, Baharlou S, Etminan M. Tattooing and risk of hepatitis B: A systematic review and meta-analysis CJPH ( 2012) 103(3) 207-212

Buxton JA, Henry B, Crabtree A, Waheed A. Prion disease risk perception in Canadian medical laboratories Can J Infect Dis Med Microbiol (2012) 23 (2) e31-35

Tu AW, Buxton JA, Stockwell T. Estimates of smoking–attributable mortality and hospitalization in BC 2002-2007. CJPH (2012) 103(2) 137-41

Ti L, Buxton J, Wood E, Zhang R, Montana J, Kerr T. Difficulty accessing crack pipes and crack pipe sharing among people who use drugs in Vancouver, Canada Substance Abuse Treatment, Prevention, and Policy 2011, 6:34

Malchy L, Bungay V, Johnson J, Buxton J Do crack smoking practices change with the introduction of safer crack kits CJPH (2011) 102 (3) 188-92

Fang L, Yu A, Buxton JA Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia, 1991 to 2007. CJID (2011) 22 (1) 10-14

Buxton JA, Henry B, Crabtree A, Waheed A, Coulthart M. Using Qualitative Methods to Investigate Risk Perception of Canadian Medical Laboratory Workers in Relation to Current Prion Disease Infection Control Policies. Prion Research in Perspectives 2010; Journal of Toxicology and Environmental Health (2011) 74 (2-4) 241-7

Buxton JA, Sebastian R, Clearsky L, Angus N, Shah L, Lem M, Spacey SD. Chasing the dragon – Characterizing cases of leukoencephalopathy associated with heroin inhalation in British Columbia, Harm Reduction Journal (2011), 8:3

Buxton JA, Kuo M, Ramji S, Yu A, Krajden M. Methadone use in relation to hepatitis C virus testing in British Columbia. CJPH (2010) 101 (6) 491-494

Jafari S, Copes R, Baharlou S, Etminan M, Buxton JA. Tattooing and Risk of Transmission of Hepatitis C: A systematic review and meta-analysis. International Journal of Infectious Diseases (2010) doi:10.1016/j.ijid.2010.03.019

Pielak K, McIntyre C, Tu A, Remple VP, Halperin B, Buxton JA Identifying attitudes, beliefs, and reported practices of nurses and doctors as immunization providers. Journal of Advanced Nursing 2010 66(7):1602-11

Buxton JA, Yu A, Kim PH, Spinelli JJ, Kuo M, Alvarez M, Gilbert M, Krajden M. HCV co-infection in HIV positive population in British Columbia, Canada BMC public health (2010) 10:225

Knowles L, Buxton JA, Skuridina N, Achebe I, LeGatt D, Fan S, Zhu N, Talbot J. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduction Journal Nov 2009 6(1):30 (HIGHLY ACCESSED)

Fang L, Yu A, Buxton JA. Identification of chronic hepatitis B and hepatitis C co-infection in British Columbia from 1991 to 2007. CJPH (2009) 100(9) 349-352

DeBeck K, Kerr T, Li K, Fischer B Buxton J, Montaner J, Wood E. Emergence of crack cocaine as a risk factor for HIV seroconversion among injection drug users in Vancouver, Canada CMAJ (2009) 181(9) 585-9

Bungay V, Johnson JL, Boyd S, Malchy L, Buxton JA, Loudfoot J. Women’s Stories/Women’s Lives: Creating Safer Crack Kits. Women’s Health and Urban Life (2009) 8(1)

Buxton JA, Skutezky T, Tu AW, Waheed B, Wallace A, Mak S. The context of illicit drug overdose deaths in British Columbia, 2006 Harm Reduction Journal ( 2009) 6:9

Tu AW, Buxton JA, Whitlock M, Djurdjev O, Chong, M, Krajden, M, Beaulieu M, Levin A. Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia. In press Can J Infect Dis (2009) 20(2) e19-23

Mackie C, Buxton JA, Tadwalkar S, Patrick D. Hepatitis B immunization strategies: Timing is everything. CMAJ (2009) 180(2):196-202

Hau D. Tyler M. Buxton J. Elliott L, Harvey B, Hockin J Mowat B. Assessing Canadian Medical Students’ familiarity with and interest in pursuing a career in community medicine. CJPH (2009) 100 (3) 194-8

Buxton JA, Rothon D, Durigon M, Lem M, Remple VP, Cook D, Krajden M. Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in BC. CJPH (2009) 100(2) 121-4

SELECTED REPORTS

Best practice recommendations for Canadian Harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV and other harms http://www.catie.ca/sites/default/files/BestPracticeRecommendations_HarmReductionProgramsCanada_Part1_August_15_2013.pdf

Decreasing HIV infections among people who use drugs by injection in British Columbia: Potential explanations an recommendations for further action. Report from the Office of the Provincial Health officer March 2011. Prepared by Gilbert M, Buxton J Tupper K. http://www.bccdc.ca/NR/rdonlyres/01022E62-AFC3-46AD-87EF-17214DEB164E/0/decreasingHIVinIDUpopulation.pdf

CHAPTERS
Buxton JA, Haden M, Mathias RG. The Regulation of Currently Illegal Drugs. In Encyclopedia of Public Health; (2008) Kirch W (Ed) publisher Springer( 2008) ISBN: 978-1-4020-5613-0

Buxton JA. Young women and methamphetamine use. Chapter 6 in Highs and Lows: Women and substance use; Karen Gelb (Ed) Julia Greenbaum, publisher Centre for Addiction and Mental Health (2007)

AREAS OF INTEREST
Harm reduction and illegal drug use epidemiology and knowledge translation
Hepatitis A, B and C, and bloodborne pathogens
Prison health participatory research
Knowledge, attitudes and behaviours regarding immunization

CURRENT RESEARCH PROJECTS & ACTIVITIES
Evaluation and research within the harm reduction program:

  • Evaluation of the take home naloxone program in BC
  • Public Knowledge and attitudes regarding harm reduction
  • Survey of drug use and risk behaviours of people who use harm reduction distribution sites

Mortality and morbidity attributable to Alcohol, illegal drugs and tobacco using administrative data and attributable fraction methodology

Co-Investigator:
Participatory prison research- HIV prevention and cancer screening
Harm reduction initiatives for people who use illicit alcohol
Knowledge synthesis methadone maintenance therapy retention

Research grants:

  • Peter wall Institute for Advanced Studies. Co-PI Bonding through Bars – protecting the health and bond of incarcerated mothers and their children.
  • Vancouver Foundation: PI: Preventing the transition of at risk youth into injection drug use

Co-I CIHR grants

  • CIHR; Cross Canada best practice recommendations for harm reduction programs
  • CIHR; Participatory prison community based HIV – prevention project
  • PHAC Participatory approach to improving cancer screening and early detection among formerly incarcerated individuals